- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03201926
Development and Clinical Application of Invalid Foods Using Mealworms
January 15, 2019 updated by: Joon Seong Park, Yonsei University
Malnutrition in cancer patients continues after surgery and worsens the patient's overall health and quality of life.
Previous studies reported edible insects in patients' diets increased postoperative muscle mass and weight gain.
Therefore, by using nutritionally excellent mealworms for a long time, it is proved that nutritional status and survival rate are improved, leading to development of various products of edible insects.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
168
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of
- Recruiting
- Gangnam Severance Hospital
-
Contact:
- JoonSeong Park
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients scheduled for surgery with pancreaticobiliary disease and liver cancer (metastatic liver cancer)
- Karnofsky performance status ≥ 70
- Patients who can communicate without difficulty in obtaining a consent form for the test
Exclusion Criteria: Patients with any of the following criteria are excluded.
- Patients who underwent palliative surgery
- Patients with uncontrolled pre-operative disease
- Previous history of surgery affecting nutritional status
- Pregnant and lactating women
- Patients with allergy to mealworms
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: mealworms
|
10g , 3 times a day , po, 2 months
|
|
Placebo Comparator: grain powder
|
grain powder, 10g ,3times one day,2months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Improvement of Body mass index
Time Frame: Changes from baseline nutition index at Preoperative 1 day, Postoperative 14 days (one week after take mealworms), Postoperative 2 months( two months after take mealworms)
|
Improvement of Nutrition index ( Body cell mass, Soft lean mass, Fat free mass, Fat mass)
|
Changes from baseline nutition index at Preoperative 1 day, Postoperative 14 days (one week after take mealworms), Postoperative 2 months( two months after take mealworms)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Improvement of Body weight change
Time Frame: Changes from baseline Body weight at Preoperative 1 day, Postoperative 14 days (one week after take mealworms), Postoperative 2 months( two months after take mealworms)
|
weight in kilograms, height in meters, BMI in kg/m^2
|
Changes from baseline Body weight at Preoperative 1 day, Postoperative 14 days (one week after take mealworms), Postoperative 2 months( two months after take mealworms)
|
|
Improvement of Immune Function Index
Time Frame: Changes from baseline nutition index at Preoperative 1 day, Postoperative 14 days (one week after take mealworms), Postoperative 2 months( two months after take mealworms)
|
Improvement of Immune parameters(T cell, INF-r, TNF-a, NK cell, IL-1, IL-2)
|
Changes from baseline nutition index at Preoperative 1 day, Postoperative 14 days (one week after take mealworms), Postoperative 2 months( two months after take mealworms)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 26, 2017
Primary Completion (Anticipated)
September 1, 2020
Study Completion (Anticipated)
December 1, 2020
Study Registration Dates
First Submitted
June 22, 2017
First Submitted That Met QC Criteria
June 26, 2017
First Posted (Actual)
June 28, 2017
Study Record Updates
Last Update Posted (Actual)
January 16, 2019
Last Update Submitted That Met QC Criteria
January 15, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3-2017-0077
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pancreatobiliary Disease; Liver Disease
-
University of FloridaCompletedPancreatobiliary Disease | Altered Gastric AnatomyUnited States
-
Yonsei UniversityUnknownDisease Status of Pancreatobiliary Tract , ( Especially Who Need to Undergo Pancreaticoduodenectomy)Korea, Republic of
-
HaEmek Medical Center, IsraelTerminatedPatients With Fatty Liver DiseaseIsrael
-
University of NottinghamNottingham University Hospitals NHS TrustRecruitingNAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Fatty Liver Disease (NAFLD) | NAFLD - Nonalcoholic Fatty Liver Disease | NAFLD (Non-alcoholic Fatty Liver Disease) | NAFLD (Nonalcoholic Fatty Liver Disease) | NAFLD - Non-Alcoholic Fatty Liver Disease | MASLD | Metabolic Dysfunction-Associated... and other conditionsUnited Kingdom
-
Chinese University of Hong KongCompletedDyspepsia | Gastroesophageal Reflux | Peptic Ulcer Disease | Pancreatobiliary Disease | Ugi MalignanciesHong Kong
-
Assiut UniversityNot yet recruitingFatty Liver Disease | Chronic Glomerular Disease
-
Assistance Publique - Hôpitaux de ParisCompletedNonalcoholic Fatty Liver Disease (NAFLD)France
-
Massachusetts General HospitalCompletedNonalcoholic Fatty Liver Disease (NAFLD)United States
-
Columbia UniversityGlaxoSmithKlineCompletedNon-Alcoholic Fatty Liver DiseaseUnited States
-
Kowa Company, Ltd.CompletedNon-Alcoholic Fatty Liver DiseaseJapan